Imvax Funding: $238M Raised, Series C (2023)

Imvax funding overview

Imvax is based in Philadelphia, Pennsylvania. Imvax has raised $238M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2023. The round record for Imvax runs through 2023; nothing later has been disclosed. Investors on record include Magnetar Capital, Ziff Capital, Wild Group Management AG, Invus Financial Advisors LLC, Fiscus Ventures. 5 distinct backers are named across the disclosed rounds.

Imvax at a glance

Total raised: $238M
Latest round: Series C
Latest round date: September 2023
Headquarters: Philadelphia, Pennsylvania
Notable investors: Magnetar Capital, Ziff Capital, Wild Group Management AG, Invus Financial Advisors LLC, Fiscus Ventures

Frequently asked about Imvax funding

How much has Imvax raised?: Imvax has raised $238M in total disclosed funding across the rounds on record.
Who has invested in Imvax?: Magnetar Capital, Ziff Capital, Wild Group Management AG, Invus Financial Advisors LLC, Fiscus Ventures are named among the investors backing Imvax.
What was the latest Imvax funding round?: The most recent disclosed round is a Series C, announced in September 2023.
Where is Imvax based?: Imvax is based in Philadelphia, Pennsylvania.
When did Imvax last raise?: The last disclosed Imvax round closed in September 2023 at Series C.

Totals shown for Imvax aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.

Imvax Funding: $238M Raised, Series C (2023)

Imvax funding overview

Imvax at a glance

Frequently asked about Imvax funding

Companies related to Imvax (22)

Browse related funding lists (3)